N-acetylaspartate: A literature review of animal research on brain ischaemia

Journal of Neurochemistry

Volumn 90, Issue 4, 2004, Pages 776-783

  Demougeot, Céline ^a,b   Marie, Christine ^a   Giroud, Maurice ^b   Beley, Alain ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Animal research; Brain ischaemia; N acetylaspartate

Indexed keywords

CELL MARKER; N ACETYLASPARTIC ACID;

AMINO ACID METABOLISM; ANIMAL MODEL; BRAIN ISCHEMIA; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; NERVE CELL; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; STROKE; SYSTEMATIC REVIEW;

ANIMALS; ASPARTIC ACID; BRAIN ISCHEMIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MAGNETIC RESONANCE SPECTROSCOPY; NEURONS;

ANIMALIA;

EID: 4143101328     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02583.x     Document Type: Review

References (112)

1. Al-Samsam R. H., Alessandri B. and Bullock R. (2000) Extracellular N-acetyl-aspartate as a biochemical marker of the severity of neuronal damage following experimental acute traumatic brain injury. J. Neurotrauma 17, 31-39.
2. Anderson K. J., Monaghan D. T., Cangro C. B., Namboodiri M. A. A., Neale J. H. and Cotman C. W. (1986) Localization of N-acetyl-aspartylglutamate-like immunoreactivity in selected areas of rat brain. Neurosci. Lett. 72, 14-20.
3. Baslow M. H. (2000) Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J. Neurochem. 75, 453-459.
4. Baslow M. H. (2002) Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem. Int. 40, 295-300.
5. Baslow M. H. (2003) N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28, 941-953.
6. Baslow M. H. and Yamada S. (1997) Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates. Exp. Eye Res. 64, 283-286.
7. Baslow M. H., Suckow R. F., Sapirstein V. and Hungund B. L. (1999) Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J. Mol. Neurosci. 13, 47-53.
8. 1H MRS studies in vivo. Neuroreport 7, 1397-1400.
9. Berger U. V., Luthi-Carter R., Passani L. A., Elkabes S., Black I., Konradi C. and Coyle J. T. (1999) Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415, 52-64.
10. Berlinguet L. and Laliberté M. (1966) Metabolism of N-acetyl-L-aspartic acid in mice. Can. J. Biochem. 44, 783-789.
11. Bhakoo K. K. and Pearce D. (2000) In vitro expression of N-acetylaspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J. Neurochem. 74, 254-262.
12. Bhakoo K. K., Craig T. J. and Styles P. (2001) Developmental and regional distribution of aspartoacylase in rat brain tissue. J. Neurochem. 79, 211-220.
13. Brinker G., Franke C., Hoehn M., Uhlenkuken U. and Hossmann K. A. (1999) Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport 10, 3269-3272.
14. Brooks K. J., Hargreaves I., Bhakoo K. et al. (2002) Delayed hypothermia prevents decreases in N-acetylaspartate and reduced glutathione in the cerebral cortex of the neonatal pig following transient hypoxia-ischaemia. Neurochem. Res. 27, 1599-15604.
15. Bruhn H., Frahm J., Gyngell M. L., Merboldt K. D., Hanicke W. and Sauter R. (1989) Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn. Reson. Med. 9, 126-131.
16. Brulatout S., Méric P., Loubinoux I. et al. (1996) A one-dimensional (proton and phosphorus) and two-dimensional (proton) in vivo NMR spectroscopic study of reversible global cerebral ischemia. J. Neurochem. 66, 2491-2499.
17. Burlina A. P., Ferrari V., Facci L., Skaper S. D. and Burlina A. B. (1997) Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate. J. Neurochem. 69, 1314-1317.
18. Cassidy M. and Neale J. H. (1993) Localization and transport of N-acetylaspartylglutamate in cells of whole murine brain in primary culture. J. Neurochem. 60, 1631-1638.
19. Curatolo A., D'Arcangelo P., Lino A. and Brancati A. (1965) Disruption of N-acetyl-aspartic and N-acetyl-aspartyl-glutamic acids in nervous tissue. J. Neurochem. 12, 339-342.
20. D'Adamo A. F., Smith J. C. and Weiler C. (1973) The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem. 20, 1275-1278.
21. D'Adamo A. F., Peisach J., Manner G. and Weiler C. T. (1977) N-acetylaspartate amidohydrolase: purification and properties. J. Neurochem. 28, 739-744.
22. Dautry C., Vaufrey F., Brouillet E., Bizat N., Henry P. G., Conde F., Bloch G. and Hantraye P. (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and in primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 20, 789-799.
23. Davie C. A., Hawkins C. P., Barker G. J., Brennan A., Tofts P. S., Miller D. H. and McDonald W. I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
24. De Stephano N., Matthews P. M. and Arnold D. L. (1995) Reversible decrease in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34, 721-727.
25. Demougeot C., Gamier P., Mossiat C., Bertrand N., Beley A. and Marie C. (2001) N-Acetylaspartate: a marker of both cellular dysfunction and neuronal loss. Its relevance to studies of acute brain injury. J. Neurochem. 77, 408-415.
26. Demougeot C., Bertrand N., Prigent-Tessier A., Gamier P., Mossiat C., Giroud M., Marie C. and Beley A. (2003) Reversible loss of N-acetyl-aspartate in rats subjected to long-term focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23, 482-489.
27. Dreher W., Kuhn B., Gyngell M. L., Busch E., Niendorf T., Hossmann K. A. and Leibfritz D. (1998) Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging. Magn. Reson. Med. 39, 878-888.
28. Federico F., Simone I. L., Lucivero V., Giannini P., Laddomada G., Mezzapesa D. M. and Tortorella C. (1998) Pronostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch. Neurol. 55, 489-494.
29. 1H-MRS of stroke. Neurology 42, 1408-1412.
30. Franke C., Brinker G., Pillekamp F. and Hoehn M. (2000) Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain. J. Cereb. Blood Flow Metab. 20, 583-591.
31. Gideon P., Henriksen O., Sperling B., Christiansen P., Olsen T. S., Jorgensen H. S. and Arlien-Soborg P. (1992) Early time-course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. Stroke 23, 1566-1572.
32. Gideon P., Sperling B., Arlien-Soborg P., Olsen T. S. and Henriksen O. (1994) Long-term follow-up of cerebral infarction with proton magnetic resonance spectroscopy. Stroke 25, 967-973.
33. Goldstein F. B. (1969) The enzymatic synthesis of N-acetyl-L-aspartatic acid by subcellular preparations of rat brain. J. Biol. Chem. 244, 4257-4260.
34. Goldstein F. B. (1976) Amidohydrolases of brain; enzymatic hydrolysis of N-acetyl-L-aspartate and other N-acyl-L-amino acids. J. Neurochem. 26, 45-49.
35. Graham G. D., Blamire A. M., Howseman A. M., Rothman D. L., Fayad P. B., Brass L. M., Petroff O. A. C., Shulman R. G. and Prichard J. W. (1992) Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23, 333-340.
36. Graham G. D., Kalvach P., Blamire A. M., Brass L. M., Fayad P. B. and Prichard J. W. (1995) Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 26, 225-229.
37. Gu W., Brannstrom T. and Wester P. (2000) Cortical neurogenesis in adult rats after reversible photothrombotic stroke. J. Cereb. Blood Flow Metab. 20, 1166-1173.
38. 31P-magnetic resonance spectroscopy. J. Tradit. Chin. Med. 21, 59-67.
39. 1H MRS, diffusion-weighted MRI, and electrophysiological monitoring. NMR Biomed. 8, 206-214.
40. 1H magnetic resonance spectroscopy in rats. Neurosurgery 38, 121-129.
41. Higuchi T., Graham S. H., Fernandez E. J., Rooney W. D., Gaspary H. L., Weiner M. W. and Maudsley A. A. (1997) Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain. Magn. Reson. Med. 37, 851-857.
42. Hoehn M., Nicholay K., Franke C. and van der Sanden B. (2001) Application of magnetic resonance to animal models of cerebral ischemia. J. Magn. Reson. Imaging 14, 491-509.
43. +-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. J. Pharmacol. Exp. Ther. 295, 392-403.
44. 1H magnetic resonance spectroscopic imaging. Ann. Neurol. 40, 236-239.
45. 1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: longitudinal metabolic changes in ischemic core and rim. Brain Res. 907, 208-221.
46. Jiang W., Gu W., Brannstrom T., Rosqvist R. and Wester P. (2001) Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke 32, 1201-1207.
47. Kalra S., Cashman N. R., Genge A. and Arnold D. L. (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9, 1757-1761.
48. Kato H. and Walz W. (2000) The initiation of the microglial response. Brain Pathol. 10, 137-143.
49. Kaul R., Casanova J., Johnson A. B., Tang P. and Matalon R. (1991) Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56, 129-135.
50. Kirino T. (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69.
51. Kirmani B. F., Jacobowitz D. M., Kallarakal A. T. and Namboodiri M. A. (2002) Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res. Mol. Brain Res. 107, 176-182.
52. Kirmani B. F., Jacobowitz D. M. and Namboodiri M. A. (2003) Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelinisation. Brain Res. Mol. Brain Res. 140, 105-115.
53. Knizley H. (1967) The enzymatic synthesis of N-acetyl-L-aspartic acid by a water-insoluble preparation of cat brain acetone powder. J. Biol. Chem. 242, 4619-4622.
54. Koller K. J. and Coyle J. T. (1984) Ontogenis of N -acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain. Brain Res. 317, 137-140.
55. Koller K. J., Zaczek R. and Coyle J. T. (1984) N-Acetyl-aspartyl glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142.
56. Konaka K., Ueda H., Li J. Y., Matsumoto M., Sakoda S. and Yanagihara T. (2003) N-Acetylaspartate to total creatine ratio in the hippocampal CA1 sector after transient cerebral ischemia in gerbils: influence of neuronal elements, reactive gliosis, and tissue atrophy. J. Cereb. Blood Flow Metab. 23, 700-708.
57. Lassen N. A. and Vorstrup S. (1984) Ischemic penumbra results in incomplete infarction: is the sleeping beauty dead? Stroke 15, 7555-7758.
58. Lemesle M., Walker P., Guy F. et al. (2000) Multi-variate analysis predicts clinical outcome 30 days after middle cerebral artery infarction. Acta Neurol. Scand. 102, 1-17.
59. Lin R. S. and Matesic D. F. (1994) Immunohistochemical demonstration of neuro-specific enolase and microtubule-associated protein 2 in reactive astrocytes after injury in the adult forebrain. Neuroscience 60, 11-16.
60. Lin R. S., Polsky K. and Matesic D. F. (1993) Expression of γ-aminobutyric acid immunoreactivity in reactive astrocytes after ischemia-induced injury in the adult forebrain. Brain Res. 600, 1-8.
61. Luthi-Carter R., Berger U. V., Barczak A. K., Enna M. and Coyle J. T. (1998) Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc. Natl Acad. Sci. USA 95, 3215-3220.
62. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M. and Matsumoto M. (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31, 1735-1743.
63. Madhavarao C. N., Chinopoulos C., Chandrasekaran K. and Namboodiri M. A. (2003) Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J. Neurochem. 86, 824-835.
64. Malisza K. L., Kozlowski P. and Peeling J. (1998) A review of in vivo IH magnetic resonance spectroscopy of cerebral ischemia in rats. Biochem. Cell Biol. 76, 487-496.
65. Malisza K. L., Kozlowski P., Ning G., Bascaramurty S. and Tuor U. I. (1999) Metabolite changes in neonatal rat brain during and after cerebral hypoxia-ischemia: a magnetic resonance spectroscopic imaging study. NMR Biomed. 12, 31-38.
66. Mandai K., Matsumoto M., Kitagawa K., Mastushita K., Ohtsuki T., Mabuchi T., Colman D. R., Kamada T. and Yanagihara T. (1997) Ischemic damage and subsequent proliferation of oligodendrocytes in focal ischemia. Neuroscience 77, 849-861.
67. Marcucci F., Mussini E., Valzelli L. and Garattini S. (1966) Distribution of N-acetyl-L-aspartic acid in rat brain. J. Neurochem. 13, 1069-1070.
68. 14C from glucose into N-acetyl-L-aspartic acid and aspartic acid in the brain perfusion experiments. J. Neurochem. 5, 379-382.
69. McIntosh J. C. and Cooper J. R. (1965) Studies on the function of N-acetylaspartic acid in brain. J. Neurochem. 12, 825-835.
70. Mehta V. and Namboodiri M. A. A. (1995) N-Acetylaspartate as an acetyl source in the nervous system. Mol. Brain Res. 31, 151-157.
71. Miyake M., Kakimoto Y. and Sorimachi M. (1981) A gas chromatographic method for the determination of N-acetyl-L-aspartic acid, N-acetyl-alpha- aspartylglutamic acid and beta-citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals. J. Neurochem. 36, 804-810.
72. Miyamoto E., Kakimotó Y. and Sano I. (1966) Identification of N-acetyl-alpha-aspartyl-glutamic acid in bovine brain. J. Neurochem. 13, 999-1003.
73. Moffett J. R. and Namboodiri M. A. (1995) Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J. Neurocytol. 24, 409-433.
74. Moffett J. R., Namboodiri M. A., Cangro C. B. and Neale J. H. (1991) Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2, 131-134.
75. Moffett J. R., Namboodiri M. A. and Neale J. H. (1993) Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41, 559-570.
76. Monsein L. H., Mathews V. P., Barker P. B., Pardo C. A., Blackband S. J., Whitlow W. D., Wong D. F. and Bryan R. N. (1993) Irreversible regional ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model. Am. J. Neuroradiol. 14, 963-970.
77. Nadler J. V. and Cooper J. R. (1972) N-acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissue. J. Neurochem. 19, 313-319.
78. Nakano M., Ueda H., Li J. Y., Matsumoto M. and Yanagihara T. (1998) Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann. Neurol. 44, 334-340.
79. Nakano M., Ueda H., Li J. Y., Matsumoto M. and Yanagihara T. (2001) A potent AMPA/kainate receptor antagonist, YM90K, attenuates the loss of N-acetylaspartate in the hippocampal CA1 area after transient unilateral forebrain ischemia in gerbils. Life Sci. 69, 1983-1990.
80. Neale J. H., Bzdega T. and Wroblewska B. (2000) N- Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 443-452.
81. Nonaka M., Yoshimine T., Kumura E., Kohmura E., Wakayama A. and Hayakawa T. (1999) Decrease in N-acetylaspartate without commensurate accumulation of acetate in focal cerebral ischemia in rat. Neurol. Res. 21, 771-774.
82. Passani L., Elkabes S. and Coyle J. T. (1998) Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia. Brain Res. 794, 143-145.
83. Patel T. B. and Clark J. B. (1979) Synthesis of N -acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184, 539-546.
84. Pavlakis S. G., Lu D., Frank Y., Wiznia A., Eidelberg D., Barnett T. and Hyman R. A. (1998) Brain lactate and N-acetylaspartate in pedriatic AIDS encephalopathy. Am. J. Neuroradiol. 19, 383-385.
85. Penrice J., Lorek A., Cady E. B. et al. (1997) Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischaemia and delayed cerebral energy failure in the newbom piglet. Pediatr. Res. 41, 795-802.
86. Pereira A. C., Saunders D. E., Doyle V. L., Bland J. M., Howe F. A., Griffiths J. R. and Brown M. M. (1999) Measurement of initial N-acetylaspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke 30, 1577-1582.
87. 1H spectroscopic imaging for evaluating the local metabolic response to focal ischemia in the conscious rat. NMR Biomed. 5, 11-19.
88. Pulsinelli W. A., Brierley J. B. and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-498.
89. Reichelt K. L. and Kvamme E. (1967) Acetylated and peptide bound glutamate and aspartate in brain. J. Neurochem. 14, 987-995.
90. Ricci P. E. (1998) Proton MR spectroscopy in ischemic stroke and other vascular disorders. Neuroimaging Clin. N. Am. 8, 881-890.
91. Robinson M. B., Blakely R. D., Couto R. and Coyle J. T. (1987) Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: identification and characterization of a novel N-acetylated-alpha-linked acidic dipeptidase acfivity from rat brain. J. Biol. Chem. 262, 14498-14506.
92. Roitberg B., Khan N., Tuccar E., Kompoliti K., Chu Y., Alperin N., Kordower J. H. and Emborg M. E. (2003) Chronic ischemic stroke model in cynomolgus monkeys: behavioural, neuroimaging and anatomical study. Neurol. Res. 25, 68-78.
93. Sager T. N., Laursen H. and Hansen A. J. (1995) Changes in N-acetylaspartate content during focal and global brain ischemia of the rat. J. Cereb. Blood Flow Metab. 15, 639-646.
94. Sager T. N., Fink-Jensen A. and Hansen A. J. (1997) Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 68, 675-682.
95. Sager T. N., Thomsen C., Laursen H., Valsborg J. S. and Hansen A. J. (1999a) Astroglia contain a specific transport mechanism for N-acetylaspartate. J. Neurochem. 73, 807-811.
96. Sager T. N., Laursen H., Fink-Jensen A., Topp S., Stensgaard A., Hedehus M., Rosenbaum S., Valsborg J. S. and Hansen A. J. (1999b) N-Acetylaspartate distribution in rat brain striatum during acute brain ischemia. J. Cereb. Blood Flow Metab. 19, 164-172.
97. Sager T. N., Hansen A. J. and Laursen H. (2000) Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 20, 780-788.
98. 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-aspartate following global ischemia be used as a reliable measure of neuronal damage. Brain Res. 892, 166-175.
99. Saunders D. E. (2000) MR spectroscopy in stroke. Br. Med. Bull 56, 334-345.
100. Saunders D. E., Howe F. A., van der Boogaart A., McLean M. A., Griffiths J. R. and Brown M. M. (1995) Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 26, 1007-1013.
101. Simmons M. L., Frodonza C. G. and Coyle J. T. (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45.
102. Slusher B. S., Robinson M. B., Tsai G., Simmons M. L., Richards S. S. and Coyle J. T. (1990) Rat brain N-acetylated alpha-linked acidic dipeptidase activity. J. Biol. Chem. 265, 21297-21301.
103. Takashima S., Chan F., Becker L. E. and Armstrong D. L. (1980) Morphology of the developing visual cortex of the human infant: a quantitative and qualitative Golgi study. J. Neuropathol. Exp. Neurol. 39, 487-501.
104. Tallan H. H. (1957) Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 224, 41-45.
105. Tallan H. H., Moore S. and Stein W. H. (1956) N-Acetyl-L-Aspartic acid in brain. J. Biol. Chem. 219, 257-264.
106. +. J. Neurochem. 62, 2349-2355.
107. van der Toom A., Verheul H. B., van der Sprenkel J. W., Tulleken C. A. and Nicolay K. (1994) Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy. Magn. Reson. Med. 32, 685-691.
108. Truckenmiller M. E., Namboodiri M. A. A., Browstein M. J. and Neale J. H. (1985) N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem. 45, 1658-1662.
109. Urenjak J., Williams S. R., Gadian D. G. and Noble M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type 2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61.
110. Urenjak J., Williams S. R., Gadian D. G. and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
111. Van Cappellen A. M., Heersschap A., Nijhuis J. G., Oeseburg B. and Jongsma H. W. (1999) Hypoxia, the subsequent systemic metabolic acidosis, and their relationship with cerebral metabolite concentrations: an in vivo study in fetal lambs with proton magnetic resonance spectroscopy. Am. J. Obstet. Gynecol. 181, 1537-1545.
112. Wardlaw J. M., Marshall I., Wild J., Dennis M. S., Cannon J. and Lewis S. C. (1998) Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relationship between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 29, 1618-1624.